Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Pharmacology
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Molecular Pharmacology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit molpharm on Facebook
  • Follow molpharm on Twitter
  • Follow molpharm on LinkedIn
Research ArticleArticle

Reversal of Persistently Stimulated Steroidogenesis by GTP and an Inhibitory Adrenocorticotropin Analogue in Adrenal Cells Pretreated with Adrenocorticotropin

D. KIRK WAYS and DAVID A. ONTJES
Molecular Pharmacology March 1979, 15 (2) 271-286;
D. KIRK WAYS
Departments of Pharmacology and Medicine, University of North Carolina School of Medicine, Chapel Hill, North Carolina 27514
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DAVID A. ONTJES
Departments of Pharmacology and Medicine, University of North Carolina School of Medicine, Chapel Hill, North Carolina 27514
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • eLetters
  • PDF
Loading

Abstract

A single addition of ACTH1-24 at concentrations of 0.1 to 10 nM to an in vitro suspension of isolated rat adrenal cells elicits a dose related steroidogenic response lasting from 150 to 240 min. The addition of fresh ACTH can initiate a new response after the spontaneous termination of the first, but persistent steroidogenesis does not require the continued presence of active hormone in the incubation medium. Biologically active hormone disappears from the extracellular medium within the first 90 min of incubation, while steroidogenesis can continue at an undiminished rate for an additional 120 min or more. Cells treated for 1 min with 100 nM ACTH, then rinsed and resuspended in hormone-free medium, produce as much cyclic AMP and corticosterone as do cells continually exposed to the same concentration of hormone. The persistent steroidogenesis seen in the ACTH-pretreated cells may be rapidly terminated by exposure of the cells to GTP or to the ACTH antagonist, ACTH6-39. These agents can also greatly accelerate the slow dissociation of bound 125I-ACTH1-24 from the cells. These findings suggest that the persistence of steroidogenesis depends upon the presence of persistently bound biologically active hormone on the exterior surface of the adrenocortical cell. The rapid displacement of bound hormone by the competitive antagonist, ACTH6-39, supports the hypothesis that there is negative cooperativity among ACTH receptors. The mechanism by which GTP increases the dissociation of bound hormone is unclear. Under the experimental conditions used, the addition of GTP to the medium does not appear to stimulate the production of cyclic AMP. GTP enhances the dissociation of the radiolabeled antagonist, 125I-ACTH6-39, as well as the dissociation of labeled agonist hormone. Thus it appears that GTP increases the dissociation of bound ACTH independently of adenylate cyclase activity, probably by interacting with sites on the cell surface and altering the ability of the receptors to bind and retain hormone.

ACKNOWLEDGMENTS We are grateful to Dr. Alton L. Steiner for his gift of cyclic AMP antisera and radiolabeled cyclic AMP. We would also like to thank Dr. John Perkins for his helpful suggestions concerning this manuscript and Ms. Celeste Layton for her assistance in the preparation of the manuscript.

  • Copyright © 1979 by Academic Press, Inc.

MolPharm articles become freely available 12 months after publication, and remain freely available for 5 years. 

Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page. 

 

  • Click here for information on institutional subscriptions.
  • Click here for information on individual ASPET membership.

 

Log in using your username and password

Forgot your user name or password?

Purchase access

You may purchase access to this article. This will require you to create an account if you don't already have one.
PreviousNext
Back to top

In this issue

Molecular Pharmacology
Vol. 15, Issue 2
1 Mar 1979
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Editorial Board (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Molecular Pharmacology article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Reversal of Persistently Stimulated Steroidogenesis by GTP and an Inhibitory Adrenocorticotropin Analogue in Adrenal Cells Pretreated with Adrenocorticotropin
(Your Name) has forwarded a page to you from Molecular Pharmacology
(Your Name) thought you would be interested in this article in Molecular Pharmacology.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleArticle

Reversal of Persistently Stimulated Steroidogenesis by GTP and an Inhibitory Adrenocorticotropin Analogue in Adrenal Cells Pretreated with Adrenocorticotropin

D. KIRK WAYS and DAVID A. ONTJES
Molecular Pharmacology March 1, 1979, 15 (2) 271-286;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Research ArticleArticle

Reversal of Persistently Stimulated Steroidogenesis by GTP and an Inhibitory Adrenocorticotropin Analogue in Adrenal Cells Pretreated with Adrenocorticotropin

D. KIRK WAYS and DAVID A. ONTJES
Molecular Pharmacology March 1, 1979, 15 (2) 271-286;
Reddit logo Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Action of Org 34167 on HCN channels
  • The effects of echinocystic acid on Kv7 channels
  • Cysteine151 in Keap1 Drives CDDO-Me Pharmacodynamic Action
Show more Articles

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Molecular Pharmacology
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0111 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics